XTAE
ABOU
Market cap442mUSD
Nov 02, Last price
540.50ILS
1D
0.11%
1Q
-5.79%
IPO
-98.97%
Name
Envizion Medical Ltd
Chart & performance
P/E
—
P/S
—
EPS
—
Vol. 1Y
88.60%
Shs. 5Y
—
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
12k
-99.45%
Net income
-50k
L-99.81%
CFO
0
P
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
ENvizion Medical Ltd. is a specialized medical device enterprise. Its primary product is the ENvue system, which streamlines the placement of feeding tubes. This innovative system achieves accuracy by integrating navigation capabilities with advanced sensors and detailed body mapping. Founded in 2017, the company maintains its headquarters in Tel Aviv-Yafo, Israel.
Key people
President, Chief Executive Officer, Co-Founder, Director
Gaby Portnoy
Chief Operating Officer · since 2019
Ran Cohen
Chief Technology Officer
Shay Tsuker
Chairman of the Board, Co-Founder, Chief Financial Officer
Valuation
Title in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT |